0001213900-21-038634.txt : 20210726
0001213900-21-038634.hdr.sgml : 20210726
20210726161521
ACCESSION NUMBER: 0001213900-21-038634
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210715
FILED AS OF DATE: 20210726
DATE AS OF CHANGE: 20210726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Townsend John
CENTRAL INDEX KEY: 0001511906
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 211114309
MAIL ADDRESS:
STREET 1: 15150 AVENUE OF SCIENCE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 5150 EL CAMINO REAL, SUITE A-32
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-15
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001511906
Townsend John
C/O UNICYCIVE THERAPEUTICS
LOS ALTOS
CA
94022
0
1
0
0
Chief Financial Officer
Stock Options
5.00
2021-07-15
4
A
0
18605
0
A
2031-07-15
Common Stock
18605
41861
D
The stock options vest equally over a period of three years from the date of grant.
/s/ John Townsend
2021-07-26